About this event
As personal Genomic medicine is moving from clinical research to a pathway of care and awareness of genetic testing is increasing, this meetup will discuss the role of digital in this space.
Genomic data requires powerful computing and complex analytical and programming capabilities. It provides detailed and unique insights into every person, with the potential to identify an individual’s risk of developing diseases or level of response to treatment.
Could genomic medicine exist without integrated digital systems or something to that effect? What is the next step in genomic medicine? Will artificial intelligence perform a more involved role in this type of medicine?
Save the date – Full Agenda TBC
5:30 PM Arrival and Networking
6:00PM - 7:30 PM Talks and Discussion
7:30PM - 8:00 PM Food and networking
Talk 1: Dr. Jonathan Massey , Health Innovation Manchester
A brief introduction to Genomics
Talk 2: Prof Christohper Yau (TBC) - Computational Biology at the Institute of Cancer and Genomic Sciences, Talk title (TBC)
Talk 3: Kevin Teburi, Managing Director, Genedata UK,
Overcoming the challenge of integrating ‘omics and patient data
Talk 4: Abdullah Sabyah , CEO and Founder of Rightangled.
"Headlights" - a personal view on the barriers and opportunities laying ahead within the current wave of the Genomics uprise.
Talk 5: Jane Theaker, CEO for Kinomica
Genomics and the rise of proteomics
Dr. Jonathan Massey: Programme Development Lead for Precision Health at Health Innovation Manchester, responsible for the delivery of a number of projects across Greater Manchester and East Cheshire, including the Psoriasis Rapid Access Clinic and ESCAPE-pain. In his previous role, he worked at The University of Manchester managing a Connected Health Cities project. He undertook research in the genetics of response to treatment in Rheumatoid Arthritis. He gained his PhD in comparative genomics at Manchester, collaborating on the FP7 LUPA project.
Kevin Teburi: Kevin joined Genedata in 2016 to found the UK subsidiary, Genedata Ltd. He heads the UK team and is part of the Genedata leadership. Prior to joining Genedata he worked at AstraZeneca Pharmaceuticals for 18 years with senior roles in R&D spanning across multiple scientific and IT disciplines as a Director of Scientific Informatics. Kevin has held numerous public speaking and consortia roles including serving as the chair and coordinator of the European Union eTRIKS IMI project in translational science and other pre-competitive organisations, he holds a degree in Biochemistry from the University of Wales, and a post graduate certificate in Health Informatics from the University of Manchester.
Abdullah Sabyah: A scientist-entrepreneur and a healthcare professional, also the CQC registered manager of Rightangled and a member of the British Heart Foundation Alliance, a member of the Clinical Pharmacogenomics Implementation Consortium in the US, and the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay (the patent is for a technology to detect DNA sequences in real-time).
Jane Theaker: Diagnostic expert with over 30 years of experience in the personalised medicine diagnostics industry. CEO of Kinomica Ltd a precision diagnostic company specialising in supplying cell-signalling insights. VP of the Genomics division of the laboratory of the government chemist (LGC) supplying products to molecular diagnostics companies and AgBio laboratories. At QIAGEN, managed the delivery team responsible for developing EGFR and KRAS cancer mutation kits to FDA standards. Invented a genomic technology which was later spun out to form DxS Ltd and sold to QIAGEN for $95 Million in 2009. Over 14 years experience at Astrazeneca in technology development to support drug development. 7 years’ experience within the NHS working in Clinical Biochemistry, helping to save lives every day.Click to Register